Multicenter, randomized, phase II trial of CI-1033, an irreversible pan-ERBB inhibitor, for previously treated advanced non small-cell lung cancer (Q40178699)
Jump to navigation
Jump to search
scientific article published on September 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Multicenter, randomized, phase II trial of CI-1033, an irreversible pan-ERBB inhibitor, for previously treated advanced non small-cell lung cancer |
scientific article published on September 2007 |
Statements
1 reference
Multicenter, randomized, phase II trial of CI-1033, an irreversible pan-ERBB inhibitor, for previously treated advanced non small-cell lung cancer (English)
1 reference
Pasi A Jänne
1 reference
Joachim von Pawel
1 reference
Roger B Cohen
1 reference
Lucio Crino
1 reference
Charles A Butts
1 reference
Steven S Olson
1 reference
Irene A Eiseman
1 reference
Alberto A Chiappori
1 reference
Beow Y Yeap
1 reference
Peter F Lenehan
1 reference
Kathy Dasse
1 reference
Meredith Sheeran
1 reference
Philip D Bonomi
1 reference
1 September 2007
1 reference
1 reference
3936-3944
1 reference
Identifiers
1 reference